Onyx Biotec Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 20-07-2024
- Paid Up Capital ₹ 13.32 Cr
as on 20-07-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.48 Cr
as on 20-07-2024
- Satisfied Charges ₹ 24.30 Cr
as on 20-07-2024
- Revenue -11.93%
(FY 2023)
- Profit -42.47%
(FY 2023)
- Ebitda -22.10%
(FY 2023)
- Net Worth 11.40%
(FY 2023)
- Total Assets 58.21%
(FY 2023)
About Onyx Biotec
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 13.32 Cr.
The company currently has active open charges totaling ₹36.48 Cr. The company has closed loans amounting to ₹24.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Kumar, Sanjay Jain, Parmjeet Kaur, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230HP2005PTC028403
- Company No.
028403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationHimachal Pradesh, Himachal Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Onyx Biotec?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Kumar  | Whole-Time Director | 27-May-2008 | Current |
| Sanjay Jain | Whole-Time Director | 27-May-2008 | Current |
| Parmjeet Kaur | Whole-Time Director | 01-Dec-2019 | Current |
| Lakshya Jain | Whole-Time Director | 02-Nov-2021 | Current |
| Harsh Mahajan | Whole-Time Director | 01-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Onyx Biotec.
Onyx Biotec Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.93% decrease. The company also saw a substantial fall in profitability, with a 42.47% decrease in profit. The company's net worth Soared by an impressive increase of 11.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onyx Biotec?
In 2023, Onyx Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rosllion Healthcare Private LimitedActive 2 years 1 monthSanjay Jain and Lakshya Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jun 2023 | ₹4.05 Cr | Open |
Axis Bank Limited Creation Date: 27 Jul 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2022 | ₹0.47 M | Open |
How Many Employees Work at Onyx Biotec?
Onyx Biotec has a workforce of 227 employees as of Jul 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onyx Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onyx Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
